Trial Details

Authorised
Basic Information
Clinical ID c3121
Identifier EUCTR2011-001332-29-AT
Trial Title Pharmacokinetics of Infliximab
Trial URL Visit Original Page
Study Information
Study Results

No results available
Conditions Inflammatory bowel disease (Ulcerative Colitis, Crohn's disease) MedDRA version: 17.0_Level: PT_Classification code 10011401_Term: Crohn's disease_System Organ Class: 10017947 - Gastrointestinal disorders_ MedDRA version: 17.0_Level: LLT_Classification code 10045365_Term: Ulcerative colitis_System Organ Class: 10017947 - Gastrointestinal disorders_;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Interventions Trade Name: Remicade Product Name: Remicade Pharmaceutical Form: Powder for solution for injection/infusion INN or Proposed INN: INFLIXIMAB CAS Number: 170277-31-3 Other descriptive name: Remicade Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration number: 10-
Participant Information
Sponsor Universitsklinik f Innere Medizin III, Klinische Abteilung f Gastroenterologie und Hepatologie
City -
Country/Region Austria
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement -
Study Design
Study Type Interventional clinical trial of medicinal product
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -